Notice: Prescription Drug List (PDL): Naloxone
Description
The purpose of this Notice of Amendment is to notify that as a result of consultation Health Canada has revised the listing for naloxone on the Prescription Drug List (PDL).
Resources
| Name |
Format |
Description |
Link |
| Notice: Prescription Drug List (PDL): Naloxone |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-naloxone.html |
| Notice: Prescription Drug List (PDL): Naloxone |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/notice-naloxone.html |